Helen is a recently widowed breast cancer patient who takes expensive brand name breast cancer medicine. She already entered the prescription drug donut hole this year and received a $250 rebate check. In 2011, she will receive a 50 percent discount on the cost of brand name drugs when she hits the donut hole, and the coverage gap will be eliminated by 2020.